Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Impact of a Program of Non-pharmacological Intervention in Patients With Type 2 Diabetes Mellitus [NA]
A completed clinical trial assessing the impact of a non-pharmacological intervention program in patients with Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics [Phase 3]
Phase 3 trial comparing the PDS290 insulin pen to a Novo Nordisk marketed insulin pen in diabetics; results were posted after completion.
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Italian Diabetes and Exercise Study 2 [NA]
A completed clinical trial in Italy studying Type 2 diabetes (Italian Diabetes and Exercise Study 2) sponsored by the Metabolic Fitness Asso…
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Efficacy and Safety of Gosogliptin as Monotherapy and in Combination With Metformin vs. Vildagliptin as Monotherapy and in Combination With Metformin in Drug-naive Type 2 Diabetic Patients. [Phase 3]
Phase 3 trial evaluating Gosogliptin as monotherapy and with metformin versus Vildagliptin as monotherapy and with metformin in drug-naive T…
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Study In People With Type 2 Diabetes [Phase 2]
Phase 2 clinical trial update for people with type 2 diabetes; the study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Computer Automation for Diagnosis and Management of Childhood Type 2 Diabetes [NA]
A completed clinical trial assessing computer automation for diagnosing and managing childhood Type 2 diabetes, with results posted in 2017.
-
CLINICAL_TRIALS research · 2017-03-23Clinical Trial Update: Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations [NA]
Clinical trial update investigating lipid and glycogen metabolism in individuals with impaired glucose tolerance and calcium-sensing recepto…
-
CLINICAL_TRIALS research · 2017-03-23Clinical Trial Update: A Nurse-led Smartphone-based Self-management Programme for Type 2 Diabetes Patients With Poor Blood Glucose Control [NA]
A clinical trial update on a nurse-led smartphone-based self-management program for adults with Type 2 diabetes mellitus and poor blood gluc…
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024) [Phase 3]
Phase 3 trial evaluating adding omarigliptin to metformin in adults with type 2 diabetes and inadequate glycemic control; completed with res…
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: A Study of LY2405319 in Participants With Type 2 Diabetes [Phase 1]
Phase 1 study of Eli Lilly's LY2405319 in participants with Type 2 diabetes has completed and results have been posted.
-
CLINICAL_TRIALS research · 2017-03-20Clinical Trial Update: The Effect of Social Relationships on Psychological Distress and Disease Progression in Patients With Diabetes [NA]
This clinical trial investigates whether social relationships influence psychological distress in patients with Type 2 diabetes and whether …
-
CLINICAL_TRIALS research · 2017-03-17Clinical Trial Update: Acute Exercise and Free-living Glycaemic Control in Type 2 Diabetes [NA]
This update describes a clinical trial investigating whether acute exercise improves free-living glycemic control in people with Type 2 diab…
-
FDA approval · 2017-03-16FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NovoLog (insulin aspart) submitted by Novo Nordisk. The entry indicates the supplement has b…
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes [Phase 4]
A Phase 4 study comparing the pharmacodynamics and pharmacokinetics of insulin aspart versus human insulin in elderly patients with Type 2 d…
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: Diabetes Mellitus Type II and Tissue Oxygenation
The clinical trial examining tissue oxygenation in individuals with Type 2 diabetes mellitus was terminated.
-
CLINICAL_TRIALS withdrawal · 2017-03-15Clinical Trial Update: Safety and Efficacy Study of Correcting Hyperglycemia in Patients With Diabetes Having Out-patient Surgery [Phase 4]
A Phase 4 clinical trial evaluating safety and efficacy of correcting hyperglycemia in patients with Type 1 or Type 2 diabetes undergoing ou…
-
CLINICAL_TRIALS withdrawal · 2017-03-15Clinical Trial Update: Measuring Patient Engagement in Diabetes Care
A Northwestern University clinical trial assessing patient engagement in type 2 diabetes care has been withdrawn.
-
FDA approval · 2017-03-14FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for JENTADUETO (linagliptin and metformin hydrochloride) submitted by Boehringer Ingelheim Pharm…
-
FDA approval · 2017-03-14FDA Approved: GLYXAMBI — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approves a supplemental application for Glyxambi (empagliflozin and linagliptin) from Boehringer Ingelheim Pharmaceuticals, Inc., seekin…
-
FDA approval · 2017-03-14FDA Approved: JENTADUETO XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for JENTADUETO XR (linagliptin and metformin hydrochloride), expanding its approved extended-rel…
-
FDA label_change · 2017-03-14FDA Approved: TRADJENTA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approves a supplemental application for TRADJENTA (linagliptin) submitted by Boehringer Ingelheim, resulting in changes to the product l…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes [NA]
A clinical trial evaluating sitagliptin for non-alcoholic steatohepatitis in patients with type 2 diabetes has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: The Diabetes Medication Choice Cards Trial in Greece [NA]
A completed clinical trial in Greece evaluating a diabetes medication choice cards tool for Type 2 diabetes, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Healthy Moms, Healthy Babies [NA]
The Healthy Moms, Healthy Babies clinical trial (NCT01578460) investigating Type 2 diabetes mellitus and gestational diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus [Phase 1]
A Phase 1 clinical trial assessing the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of PF-04937319 in adults…